Research and Markets: Annals Meeting Reports - Reports from Three Recent Scientific Meetings - 2011 Edition

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/a89b27/annals_meeting_rep) has announced the addition of John Wiley and Sons Ltd's new book "Annals Meeting Reports - Reports from Three Recent Scientific Meetings" to their offering.

This volume presents reports from three recent scientific meetings on topics in emerging fields.

The first report comes from the New York Stem Cell Foundation's Fifth Annual Translational Stem Cell Research Conference convened in October 2010 at the Rockefeller University in New York City. The conference attracted over 400 scientists, patient advocates, and stem cell research supporters from 16 countries. Compiled by young stem cell scientists, this report summarizes the excellent, groundbreaking progress in stem cell research.

The next report covers a conference on behavioral epigenetics sponsored by the New York Academy of Sciences and the Warren Alpert Medical School of Brown University in October 2010 at the University of Massachusetts Boston Campus Center. This meeting featured speakers and panel discussions exploring the emerging field of behavioral epigenetics, from basic biochemical and cellular mechanisms to the epigenetic modulation of normative development, developmental disorders, and psychopathology. This report provides an overview of the research presented by leading scientists and lively discussion about the future of investigation at the behavioral epigenetic level.

The final report discusses the work presented at the 2nd Pepducin Science Symposium held in Cambridge, Massachusetts in November 2010. This meeting report summarizes the symposium proceedings that focused on increasing knowledge of the structure and function of this ubiquitous superfamily of membrane receptors and their potential modulation for disease treatment, and how GPCR mechanisms might be exploited to treat diseases with pepducins, novel synthetic lipopeptide pharmacophores that modulate heptahelical GPCR activity from inside the cell membrane.

For more information visit http://www.researchandmarkets.com/research/a89b27/annals_meeting_rep



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Research  Other Science  Science

MEDIA:

Logo
 Logo

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.